Tag: file-photo
-
U.S. Senate panel postpones Mylan hearing
The U.S. Senate Judiciary Committee on Monday postponed a hearing planned for next week to discuss Mylan NV's pending $465 million settlement to resolve charges that it underpaid government healthcare programs by misclassifying its EpiPen emergency allergy treatment. Mylan, the Justice Department and the Centers for Medicare and Medicaid Services had all declined to send…
-
Judge questions vow not to use sedative again in executions
PHOENIX (AP) — A judge presiding over a lawsuit that protests how Arizona carries out the death penalty extracted promises in court from the state Wednesday that it won't use the sedative midazolam in future executions.
-
Judge questions vow not to use sedative again in executions
PHOENIX (AP) — A judge presiding over a lawsuit that protests how Arizona carries out the death penalty extracted promises in court from the state Wednesday that it won't use the sedative midazolam in future executions.
-
Mylan to pay $465 million over EpiPen Medicaid rebate dispute
Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, which has come under intense scrutiny after a series of drastic price increases. Mylan has been lambasted by consumers and lawmakers for raising prices on the lifesaving…
-
Mylan to pay $465 million over EpiPen Medicaid rebate dispute
Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, which has come under intense scrutiny after a series of drastic price increases. Mylan has been lambasted by consumers and lawmakers for raising prices on the lifesaving…
-
Mylan to pay $465 mn over EpiPen overcharges to Medicaid
Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday. The settlement with the Department of Justice and some other regulators resolves questions about Mylan's classification of EpiPen as a generic drug, the drugmaker said. Mylan said it…
-
Mylan to pay $465 mn over EpiPen overcharges to Medicaid
Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday. The settlement with the Department of Justice and some other regulators resolves questions about Mylan's classification of EpiPen as a generic drug, the drugmaker said. Mylan said it…
-
Hurricane Matthew death toll passes 800 in Haiti, cholera takes lives
By Makini Brice and Joseph Guyler Delva CHANTAL, Haiti/PORT-AU-PRINCE (Reuters) – Hurricane Matthew's trail of destruction in Haiti stunned those emerging from the aftermath on Friday, with the number of dead soaring to 842, tens of thousands homeless and outbreaks of cholera already claiming more lives. Information trickled in from remote areas that were cut…
-
Senators ask Justice Dept to consider probe of EpiPen Medicaid classification
U.S. Senators Richard Blumenthal, Charles Grassley and Amy Klobuchar asked the Justice Department to investigate whether Mylan NV may have misclassified its EpiPen in order to pay lower rebates to the states. In a letter released on Wednesday, the lawmakers noted that Mylan classified the EpiPen with the Medicaid Drug Rebate Program as a non-innovator…
-
Thais probe babies with microcephaly for Zika link
Thai doctors are running tests to see whether Zika was the cause of microcephaly in two babies whose mothers are infected with the mosquito-borne virus, a health official said Wednesday. If the remaining pair are found to be linked, they could be the first case of Zika-related microcephaly in Southeast Asia, according to the World…